The incidence of target-lesion revascularization was 6.5, 9.0, and 10.2% at 6, 12 and 24 months, respectively. The MELODIE trial also demonstrated the safety of iliac artery revascularization with ...

Adapted from: Andersen BK. Quantitative flow ratio or fractional flow reserve for guiding coronary revascularization. Presented at: TCT 2024. Washington, DC. Patients whose coronary revascularization ...

Wearable devices can reduce cardiovascular events and death in ischemic heart disease, according to a new meta-analysis, but ...

The following is a summary of “Effects of Novel Antidiabetic Agents on Contrast-Associated Acute Kidney Injury in Diabetic Patients Undergoing Percutaneous Coronary Intervention,” published in the ...

A new therapeutic device, the Coronary Sinus Reducer (CSR), is making waves in the treatment of refractory angina, providing ...